Fresenius Medical Care (FMS) PT Raised to $42 at RBC Capital
Tweet
Share
E-mailGet Alerts FMS Hot Sheet
Price: $23.50 -1.14%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Fresenius Medical Care (NYSE: FMS) to $42.00 (from $40.00) while maintaining a Sector Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
